XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies - Narrative (Details)
 3 Months Ended 12 Months Ended
Aug. 12, 2021
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
segment
$ / shares
shares
Dec. 31, 2023
USD ($)
shares
Dec. 17, 2024
$ / shares
Mar. 04, 2024
Jan. 12, 2024
$ / shares
Nov. 09, 2023
$ / shares
Nov. 08, 2023
shares
Feb. 23, 2023
$ / shares
Cash and Cash Equivalents [Line Items]                    
Restricted cash, non-current     $ 0 $ 373,000            
Allowance for doubtful accounts     0 0            
Deferred fulfillment and prepaid launch costs     2,600,000 1,700,000            
Recorded revenue     1,800,000 300,000            
Contract with customer, liability     2,200,000 1,000,000.0            
Contract liabilities, non-current     1,901,000 998,000            
Service revenue     2,114,000 3,089,000            
Contract with customer, liability       300,000            
Warrants and rights outstanding, term (in years)           5 years 5 years      
Payment of liability   $ 10,000,000                
Number of warrants outstanding (in shares) | shares                 122,572  
Exercise price (in dollars per share) | $ / shares         $ 6.82   $ 13.44 $ 28.00   $ 805.00
Issuance of pre-funded warrants and warrants in private placement, net of issuance costs     2,443,000              
Estimated fair value of warrants     3,000 3,000            
Impairments of long-lived assets     0 0            
Defined contribution plan, cost     $ 0 $ 0            
Number of reportable segments | segment     1              
Number of operating segments | segment     1              
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Geographic Distribution, Foreign                    
Cash and Cash Equivalents [Line Items]                    
Percentage of derived from customers     14.00%              
Restricted Stock Units                    
Cash and Cash Equivalents [Line Items]                    
Expected term     6 months              
ESPP                    
Cash and Cash Equivalents [Line Items]                    
Offering period     6 months              
Common Class A                    
Cash and Cash Equivalents [Line Items]                    
Warrants and rights outstanding, term (in years)     5 years              
Exchange ratio     1              
Exercise price (in dollars per share) | $ / shares     $ 8,050   $ 6.08          
Expiration period     5 years              
Common Class B                    
Cash and Cash Equivalents [Line Items]                    
Warrants and rights outstanding, term (in years)     1 year 6 months              
Private Placement Warrant                    
Cash and Cash Equivalents [Line Items]                    
Number of warrants outstanding (in shares) | shares     16,104 16,104            
Estimated fair value of warrants $ 31,200,000                  
Public Warrant                    
Cash and Cash Equivalents [Line Items]                    
Number of warrants outstanding (in shares) | shares     12,322 12,322            
Issuance of pre-funded warrants and warrants in private placement, net of issuance costs $ 20,200,000                  
Patents                    
Cash and Cash Equivalents [Line Items]                    
Intangible asset useful life     10 years              
Prepaid Expenses and Other Current Assets                    
Cash and Cash Equivalents [Line Items]                    
Deferred fulfillment and prepaid launch costs     $ 0 $ 1,300,000            
Other Noncurrent Assets                    
Cash and Cash Equivalents [Line Items]                    
Deferred fulfillment and prepaid launch costs     2,600,000 400,000            
Cash Designated for Collateral                    
Cash and Cash Equivalents [Line Items]                    
Restricted cash, non-current     $ 0 $ 400,000